Doblingskadidat !!!!

Vi kan se bort fra Canada, to klinikker blir det ikke penger av.

I USA er det flere enn 100 operative klinikker og det er så vidt det gir omsetning.......

Virker ikke til å ha fått noen flere i USA siden forrige kvartalspresentasjon heller, ref cysview.com.

Enten det eller så oppdaterer de ikke siden, noe som I tilfellet tyder på en meget dårlig salgsjobb.

Sendte dem (cysview.com) et spørsmål om de kunne oppdatere oversikten siden det bare er nevnt 63 klinikker på kartet, mens de i teksten på hovedsiden refererer til over 100. Fikk ikke noe svar, noe som vel kan tyde på det siste. Vet ikke hva som er verst...

Ok, takk. Det var nytt for meg, og litt overraskende må jeg si.

Synes uansett et svar hadde vært på sin plass. Er jo pasienter som lurer på slikt.

Toronto Sun: Humber Hospital has the pulse of the community. 25.01.2018

Pee Patrol
If you pee pink, run! To your doctor!

Blood in your urine is one sign of bladder cancer and early detection is critical. Humber River is the first hospital in Canada using revolutionary diagnostic technology, Cysview Blue Light Cystoscopy, for detection of non-muscle invasive bladder cancer (NMIBC).

This new technology picks up tumours missed by conventional white-light cystoscopy. There has been little advancement over the years in bladder cancer detection – now Cysview offers bladder cancer survivors the chance to undergo less frequent invasive surgeries and experience an improved recurrence rate or even be cancer free.

This drug-device combination allows urologists to find non-muscle invasive bladder cancer more easily and completely remove tumours before they invade deeper layers of the bladder wall and beyond into surrounding areas. Malignant cells fluoresce bright pink during the scope procedure so that urologists can see a clear demarcation between healthy versus tumorous tissue inside the bladder.

Dr. Jack Barkin, a prominent urologist at Humber, is excited about leading the charge with the innovative technology and says it’s just the beginning of improved care and better outcomes for bladder cancer patients in Canada. “It’s a real game changer in urology – bladder cancer is so common and we know there’s a high recurrence rate.”

Bladder cancer is the fifth most common cancer in Canada, the fourth most common in men, and 80% are classified as NMIBC. “It’s the most expensive cancer to treat and recurrence is still a significant problem in the management of NMIBC,” says Barkin, adding that it has an overall rate of recurrence of up to 61% at one year and 78% at five years.

In 2014, 8,000 Canadians were diagnosed with bladder cancer – that year there were 2,200 deaths from bladder cancer. The current treatment is inadequate and costly, says Barkin, adding that “early diagnosis of NMIBC is essential to minimizing the risk of recurrence or progression to muscle invasive disease.”

http://torontosun.com/health/diet-fitness/humber-hospital-has-the-pulse-of-the-community

jeg tror utsettelsen av q4 kan tolkes positivt. Enten får de tillatelsen fra FDA, eller så har de gode starttall etter refusjonen begynte 1. jan. Etter den begredelige q3 kursmasakeren, så har sjefen noen ess i ermet denne gangen.